英文名稱 Anti-CD44v7

中文名稱 CD44V7抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg 0.2ml/200μg

抗體來源 Rabbit

交叉反應(yīng) Human

產(chǎn)品類型 一抗

研究領(lǐng)域 腫瘤

蛋白分子量 predicted molecular weight: 37kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humanCD44v7

亞 型 IgG

純化方法 affinity purified by Protein A

儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:2000-5000 IP= IHC-P=1:50-200IHC-F=1:50-200 IF=1:50-200

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件  Store at -20 °C for one year.

別 名 CD44 antigen isoform 7 precursor; LHR; BA-1; CD 44;CD44; CD44 antigen; CD44 molecule; CD44_HUMAN; CDw44; Cell surface glycoproteinCD44; chondroitin sulfate proteoglycan 8; ECMR-III; Epican; Extracellularmatrix receptor III; GP90 lymphocyte homing/adhesion receptor; hematopoieticcell E- and L-selectin ligand; Heparan sulfate proteoglycan; Hermes antigen;homing function and Indian blood group system; HSA; HUTCH-I; HUTCH1;Hyaluronate receptor; MDU2; MDU3; MIC4; MUTCH1; PGP-1; PGP1; Phagocyticglycoprotein 1; Phagocytic glycoprotein I.